KLRA Kailera Therapeutics, Inc.
Company Analysis
Latest News
🟢 KLRA extends move to 5.1% up
KLRA is trading at $21.89, up 5.1% versus the comparison close of $20.83 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 KLRA is trading 4.5% up today amid GLP-1 sector enthusiasm and post-IPO volatility
KLRA is trading 4.5% up today at $21.76 as the stock continues to experience post-IPO volatility alongside broader enthusiasm for the obesity and GLP-1 drug...
🔴 KLRA is trading 4% down today amid Q1 2026 earnings report
KLRA is trading 4% down today at $20.51 as the company is expected to report its Q1 2026 earnings today, June 25, 2026. • As a recently listed clinical-stage...
🟢 KLRA is trading 6% up today as it rebounds from a recent pullback
KLRA is trading at $22.65 (up 6%), rebounding from the prior session’s pullback and continuing its highly volatile post-IPO trading pattern. • The stock has...
🔴 KLRA extends move to 5.0% down
KLRA is trading at $21.73, down 5.0% versus the comparison close of $22.88 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 KLRA is trading 4.5% down today on profit-taking after recent rally
KLRA is trading 4.5% down at $21.86 on apparent profit-taking following a sharp multi-day rally. • The pullback follows significant gains of approximately 15%...
🟢 KLRA makes sharp 10.5% jump
KLRA is trading at $21.98, up 10.5% versus the comparison close of $19.90 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Kailera Therapeutics, Inc. extends move to 5.5% up
KLRA is trading at $20.99, up 5.5% versus the comparison close of $19.90 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Kailera Therapeutics, Inc. is trading 6.3% up today, extending its multi-day momentum with no clear catalyst
Kailera Therapeutics, Inc. is trading at $21.15 (6.3%) up in pre-market, extending its recent multi-day uptrend despite a lack of fresh company-specific news...
🟢 Kailera Therapeutics, Inc. extends move to 5.3% up
KLRA is trading at $20.14, up 5.3% versus the comparison close of $19.13 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Kailera Therapeutics, Inc. is trading 4.6% up today, extending a rebound from its June 16 decline
Kailera Therapeutics, Inc. is trading at $20.02, up 4.6%, extending a rebound that started after its June 16 decline. • Recent news and filings show no fresh...
🟢 Kailera Therapeutics, Inc. is trading 5.1% up today as shares rebound from recent losses
Kailera Therapeutics, Inc. is trading 5.1% up at $19.50 as the stock appears to be rebounding from a 5.7% drop on June 16. • The move comes despite a lack of...
🔴 Kailera Therapeutics, Inc. extends move to 5.5% down
KLRA is trading at $18.58, down 5.5% versus the comparison close of $19.67 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 Kailera Therapeutics, Inc. is trading 4.5% down today on apparent profit-taking
Kailera Therapeutics, Inc. is trading 4.5% down at $18.79 today on apparent profit-taking following recent post-IPO strength. • There are no fresh...
🟢 Kailera Therapeutics, Inc. extends move to 5.7% up
KLRA is trading at $19.96, up 5.7% versus the comparison close of $18.89 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Kailera Therapeutics, Inc. is trading 1.9% up today amid a broader biotech rally and post-IPO price discovery
Kailera Therapeutics, Inc. is trading at $19.24 (up 1.9%) as the stock recovers from recent post-IPO volatility amid a broader rally in the biotechnology...